nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Sorafenib—thyroid cancer	0.15	0.293	CbGbCtD
Sitagliptin—ABCB1—Sorafenib—thyroid cancer	0.102	0.198	CbGbCtD
Sitagliptin—CYP3A4—Vandetanib—thyroid cancer	0.101	0.197	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—thyroid cancer	0.0617	0.12	CbGbCtD
Sitagliptin—CYP3A4—Sorafenib—thyroid cancer	0.0609	0.119	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—thyroid cancer	0.037	0.0721	CbGbCtD
Sitagliptin—Arthralgia—Vandetanib—thyroid cancer	0.00226	0.00464	CcSEcCtD
Sitagliptin—Renal failure—Sorafenib—thyroid cancer	0.00225	0.00462	CcSEcCtD
Sitagliptin—Anxiety—Vandetanib—thyroid cancer	0.00225	0.00462	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00225	0.00461	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00224	0.00461	CcSEcCtD
Sitagliptin—Dry mouth—Vandetanib—thyroid cancer	0.00221	0.00454	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00217	0.00445	CcSEcCtD
Sitagliptin—Parosmia—Doxorubicin—thyroid cancer	0.00216	0.00443	CcSEcCtD
Sitagliptin—Infection—Vandetanib—thyroid cancer	0.00215	0.00442	CcSEcCtD
Sitagliptin—Lung disorder—Epirubicin—thyroid cancer	0.00214	0.00439	CcSEcCtD
Sitagliptin—Nervous system disorder—Vandetanib—thyroid cancer	0.00212	0.00436	CcSEcCtD
Sitagliptin—Skin disorder—Vandetanib—thyroid cancer	0.0021	0.00432	CcSEcCtD
Sitagliptin—Urinary tract disorder—Sorafenib—thyroid cancer	0.00203	0.00417	CcSEcCtD
Sitagliptin—Connective tissue disorder—Sorafenib—thyroid cancer	0.00202	0.00415	CcSEcCtD
Sitagliptin—Urethral disorder—Sorafenib—thyroid cancer	0.00202	0.00414	CcSEcCtD
Sitagliptin—Herpes zoster—Epirubicin—thyroid cancer	0.00201	0.00413	CcSEcCtD
Sitagliptin—Lung disorder—Doxorubicin—thyroid cancer	0.00198	0.00406	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00197	0.00405	CcSEcCtD
Sitagliptin—Insomnia—Vandetanib—thyroid cancer	0.00196	0.00402	CcSEcCtD
Sitagliptin—Erythema multiforme—Sorafenib—thyroid cancer	0.00194	0.00399	CcSEcCtD
Sitagliptin—Cardiac disorder—Sorafenib—thyroid cancer	0.00191	0.00392	CcSEcCtD
Sitagliptin—Dyspepsia—Vandetanib—thyroid cancer	0.00191	0.00391	CcSEcCtD
Sitagliptin—Decreased appetite—Vandetanib—thyroid cancer	0.00188	0.00386	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00187	0.00384	CcSEcCtD
Sitagliptin—Fatigue—Vandetanib—thyroid cancer	0.00187	0.00383	CcSEcCtD
Sitagliptin—Angiopathy—Sorafenib—thyroid cancer	0.00187	0.00383	CcSEcCtD
Sitagliptin—Herpes zoster—Doxorubicin—thyroid cancer	0.00186	0.00382	CcSEcCtD
Sitagliptin—Immune system disorder—Sorafenib—thyroid cancer	0.00186	0.00381	CcSEcCtD
Sitagliptin—Mediastinal disorder—Sorafenib—thyroid cancer	0.00185	0.0038	CcSEcCtD
Sitagliptin—Pain—Vandetanib—thyroid cancer	0.00185	0.0038	CcSEcCtD
Sitagliptin—Constipation—Vandetanib—thyroid cancer	0.00185	0.0038	CcSEcCtD
Sitagliptin—Mental disorder—Sorafenib—thyroid cancer	0.0018	0.0037	CcSEcCtD
Sitagliptin—Malnutrition—Sorafenib—thyroid cancer	0.00179	0.00367	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00177	0.00364	CcSEcCtD
Sitagliptin—Muscle spasms—Sorafenib—thyroid cancer	0.00172	0.00353	CcSEcCtD
Sitagliptin—Abdominal pain—Vandetanib—thyroid cancer	0.00171	0.00351	CcSEcCtD
Sitagliptin—Cellulitis—Epirubicin—thyroid cancer	0.00166	0.00342	CcSEcCtD
Sitagliptin—Angioedema—Sorafenib—thyroid cancer	0.00164	0.00336	CcSEcCtD
Sitagliptin—Cough—Sorafenib—thyroid cancer	0.00156	0.00321	CcSEcCtD
Sitagliptin—Asthenia—Vandetanib—thyroid cancer	0.00155	0.00319	CcSEcCtD
Sitagliptin—Hypertension—Sorafenib—thyroid cancer	0.00155	0.00317	CcSEcCtD
Sitagliptin—Cellulitis—Doxorubicin—thyroid cancer	0.00154	0.00316	CcSEcCtD
Sitagliptin—Neck pain—Epirubicin—thyroid cancer	0.00153	0.00314	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00153	0.00314	CcSEcCtD
Sitagliptin—Myalgia—Sorafenib—thyroid cancer	0.00152	0.00313	CcSEcCtD
Sitagliptin—Arthralgia—Sorafenib—thyroid cancer	0.00152	0.00313	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00151	0.00311	CcSEcCtD
Sitagliptin—Dry mouth—Sorafenib—thyroid cancer	0.00149	0.00306	CcSEcCtD
Sitagliptin—Diarrhoea—Vandetanib—thyroid cancer	0.00148	0.00304	CcSEcCtD
Sitagliptin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00146	0.003	CcSEcCtD
Sitagliptin—Infection—Sorafenib—thyroid cancer	0.00145	0.00298	CcSEcCtD
Sitagliptin—Nervous system disorder—Sorafenib—thyroid cancer	0.00143	0.00294	CcSEcCtD
Sitagliptin—Dizziness—Vandetanib—thyroid cancer	0.00143	0.00294	CcSEcCtD
Sitagliptin—Skin disorder—Sorafenib—thyroid cancer	0.00142	0.00291	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00142	0.00291	CcSEcCtD
Sitagliptin—Neck pain—Doxorubicin—thyroid cancer	0.00142	0.00291	CcSEcCtD
Sitagliptin—Vomiting—Vandetanib—thyroid cancer	0.00138	0.00283	CcSEcCtD
Sitagliptin—Rash—Vandetanib—thyroid cancer	0.00137	0.0028	CcSEcCtD
Sitagliptin—Dermatitis—Vandetanib—thyroid cancer	0.00136	0.0028	CcSEcCtD
Sitagliptin—Headache—Vandetanib—thyroid cancer	0.00136	0.00279	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00133	0.00273	CcSEcCtD
Sitagliptin—Nausea—Vandetanib—thyroid cancer	0.00129	0.00264	CcSEcCtD
Sitagliptin—Dyspepsia—Sorafenib—thyroid cancer	0.00129	0.00264	CcSEcCtD
Sitagliptin—Decreased appetite—Sorafenib—thyroid cancer	0.00127	0.00261	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00126	0.00259	CcSEcCtD
Sitagliptin—Fatigue—Sorafenib—thyroid cancer	0.00126	0.00259	CcSEcCtD
Sitagliptin—Constipation—Sorafenib—thyroid cancer	0.00125	0.00256	CcSEcCtD
Sitagliptin—Pain—Sorafenib—thyroid cancer	0.00125	0.00256	CcSEcCtD
Sitagliptin—Eczema—Epirubicin—thyroid cancer	0.00122	0.00251	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00119	0.00245	CcSEcCtD
Sitagliptin—Renal failure acute—Epirubicin—thyroid cancer	0.00119	0.00244	CcSEcCtD
Sitagliptin—Urticaria—Sorafenib—thyroid cancer	0.00116	0.00238	CcSEcCtD
Sitagliptin—Abdominal pain—Sorafenib—thyroid cancer	0.00116	0.00237	CcSEcCtD
Sitagliptin—Renal impairment—Epirubicin—thyroid cancer	0.00115	0.00237	CcSEcCtD
Sitagliptin—Eczema—Doxorubicin—thyroid cancer	0.00113	0.00232	CcSEcCtD
Sitagliptin—Hypoglycaemia—Epirubicin—thyroid cancer	0.00113	0.00231	CcSEcCtD
Sitagliptin—Renal failure acute—Doxorubicin—thyroid cancer	0.0011	0.00226	CcSEcCtD
Sitagliptin—Pain in extremity—Epirubicin—thyroid cancer	0.0011	0.00226	CcSEcCtD
Sitagliptin—Osteoarthritis—Epirubicin—thyroid cancer	0.0011	0.00226	CcSEcCtD
Sitagliptin—Migraine—Epirubicin—thyroid cancer	0.00108	0.00222	CcSEcCtD
Sitagliptin—Hypersensitivity—Sorafenib—thyroid cancer	0.00108	0.00221	CcSEcCtD
Sitagliptin—Renal impairment—Doxorubicin—thyroid cancer	0.00107	0.00219	CcSEcCtD
Sitagliptin—Face oedema—Epirubicin—thyroid cancer	0.00106	0.00218	CcSEcCtD
Sitagliptin—Asthenia—Sorafenib—thyroid cancer	0.00105	0.00215	CcSEcCtD
Sitagliptin—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00104	0.00214	CcSEcCtD
Sitagliptin—Blood creatinine increased—Epirubicin—thyroid cancer	0.00103	0.00211	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—thyroid cancer	0.00102	0.00209	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—thyroid cancer	0.00102	0.00209	CcSEcCtD
Sitagliptin—Abdominal pain upper—Epirubicin—thyroid cancer	0.001	0.00206	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.001	0.00206	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—thyroid cancer	0.001	0.00205	CcSEcCtD
Sitagliptin—Diarrhoea—Sorafenib—thyroid cancer	0.001	0.00205	CcSEcCtD
Sitagliptin—Breast disorder—Epirubicin—thyroid cancer	0.000993	0.00204	CcSEcCtD
Sitagliptin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000983	0.00202	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—thyroid cancer	0.000982	0.00201	CcSEcCtD
Sitagliptin—Dizziness—Sorafenib—thyroid cancer	0.000966	0.00198	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000952	0.00195	CcSEcCtD
Sitagliptin—Influenza—Epirubicin—thyroid cancer	0.00095	0.00195	CcSEcCtD
Sitagliptin—Pancreatitis—Epirubicin—thyroid cancer	0.000931	0.00191	CcSEcCtD
Sitagliptin—Vomiting—Sorafenib—thyroid cancer	0.000929	0.00191	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000929	0.00191	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000929	0.00191	CcSEcCtD
Sitagliptin—Rash—Sorafenib—thyroid cancer	0.000921	0.00189	CcSEcCtD
Sitagliptin—Dermatitis—Sorafenib—thyroid cancer	0.000921	0.00189	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—thyroid cancer	0.000919	0.00189	CcSEcCtD
Sitagliptin—Headache—Sorafenib—thyroid cancer	0.000915	0.00188	CcSEcCtD
Sitagliptin—Bronchitis—Epirubicin—thyroid cancer	0.000913	0.00187	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000909	0.00187	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000883	0.00181	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—thyroid cancer	0.000879	0.0018	CcSEcCtD
Sitagliptin—Nausea—Sorafenib—thyroid cancer	0.000868	0.00178	CcSEcCtD
Sitagliptin—Weight increased—Epirubicin—thyroid cancer	0.000864	0.00177	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—thyroid cancer	0.000862	0.00177	CcSEcCtD
Sitagliptin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000857	0.00176	CcSEcCtD
Sitagliptin—Pneumonia—Epirubicin—thyroid cancer	0.000852	0.00175	CcSEcCtD
Sitagliptin—Infestation—Epirubicin—thyroid cancer	0.000847	0.00174	CcSEcCtD
Sitagliptin—Infestation NOS—Epirubicin—thyroid cancer	0.000847	0.00174	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—thyroid cancer	0.000845	0.00173	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00084	0.00172	CcSEcCtD
Sitagliptin—Renal failure—Epirubicin—thyroid cancer	0.000832	0.00171	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00083	0.0017	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—thyroid cancer	0.000823	0.00169	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000817	0.00168	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000801	0.00164	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—thyroid cancer	0.0008	0.00164	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—thyroid cancer	0.000794	0.00163	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000793	0.00163	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—thyroid cancer	0.000788	0.00162	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—thyroid cancer	0.000783	0.00161	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—thyroid cancer	0.000783	0.00161	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000777	0.00159	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—thyroid cancer	0.00077	0.00158	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000768	0.00158	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000762	0.00156	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000756	0.00155	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—thyroid cancer	0.000754	0.00155	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000751	0.00154	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—thyroid cancer	0.000749	0.00154	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000747	0.00153	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—thyroid cancer	0.000745	0.00153	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000741	0.00152	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—thyroid cancer	0.000735	0.00151	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—thyroid cancer	0.000719	0.00148	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—thyroid cancer	0.00071	0.00146	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—thyroid cancer	0.000705	0.00145	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0007	0.00144	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—thyroid cancer	0.000698	0.00143	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000695	0.00143	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000693	0.00142	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000691	0.00142	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—thyroid cancer	0.00069	0.00142	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—thyroid cancer	0.000689	0.00141	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—thyroid cancer	0.000687	0.00141	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000685	0.00141	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—thyroid cancer	0.000666	0.00137	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000665	0.00136	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—thyroid cancer	0.000662	0.00136	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—thyroid cancer	0.000657	0.00135	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000653	0.00134	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—thyroid cancer	0.000652	0.00134	CcSEcCtD
Sitagliptin—Tension—Epirubicin—thyroid cancer	0.000649	0.00133	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—thyroid cancer	0.000643	0.00132	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—thyroid cancer	0.00064	0.00131	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—thyroid cancer	0.000638	0.00131	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—thyroid cancer	0.000636	0.00131	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—thyroid cancer	0.000635	0.0013	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000634	0.0013	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—thyroid cancer	0.000624	0.00128	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—thyroid cancer	0.000616	0.00126	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000614	0.00126	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—thyroid cancer	0.000612	0.00126	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—thyroid cancer	0.000603	0.00124	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—thyroid cancer	0.000601	0.00123	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—thyroid cancer	0.000597	0.00122	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—thyroid cancer	0.000595	0.00122	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—thyroid cancer	0.000595	0.00122	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—thyroid cancer	0.000592	0.00122	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—thyroid cancer	0.000589	0.00121	CcSEcCtD
Sitagliptin—Cough—Epirubicin—thyroid cancer	0.000577	0.00119	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—thyroid cancer	0.000577	0.00118	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—thyroid cancer	0.000571	0.00117	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000568	0.00117	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—thyroid cancer	0.000563	0.00116	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—thyroid cancer	0.000563	0.00116	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—thyroid cancer	0.000561	0.00115	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000559	0.00115	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—thyroid cancer	0.000557	0.00114	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—thyroid cancer	0.000552	0.00113	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—thyroid cancer	0.000551	0.00113	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—thyroid cancer	0.00055	0.00113	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—thyroid cancer	0.00054	0.00111	CcSEcCtD
Sitagliptin—Infection—Epirubicin—thyroid cancer	0.000537	0.0011	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—thyroid cancer	0.000534	0.0011	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—thyroid cancer	0.00053	0.00109	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—thyroid cancer	0.000529	0.00108	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—thyroid cancer	0.000525	0.00108	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—thyroid cancer	0.000521	0.00107	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—thyroid cancer	0.000521	0.00107	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—thyroid cancer	0.000519	0.00107	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000518	0.00106	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—thyroid cancer	0.000515	0.00106	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—thyroid cancer	0.00051	0.00105	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0005	0.00103	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—thyroid cancer	0.000496	0.00102	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000492	0.00101	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—thyroid cancer	0.00049	0.00101	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—thyroid cancer	0.000488	0.001	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—thyroid cancer	0.000485	0.000996	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—thyroid cancer	0.00048	0.000985	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—thyroid cancer	0.000475	0.000976	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—thyroid cancer	0.000469	0.000963	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000466	0.000957	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—thyroid cancer	0.000466	0.000956	CcSEcCtD
Sitagliptin—Pain—Epirubicin—thyroid cancer	0.000462	0.000948	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—thyroid cancer	0.000462	0.000948	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000455	0.000934	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—thyroid cancer	0.000452	0.000928	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—thyroid cancer	0.000445	0.000913	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—thyroid cancer	0.000444	0.000912	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000442	0.000906	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—thyroid cancer	0.00044	0.000903	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—thyroid cancer	0.000434	0.000891	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000431	0.000885	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—thyroid cancer	0.000431	0.000884	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—thyroid cancer	0.000429	0.000881	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—thyroid cancer	0.000427	0.000877	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—thyroid cancer	0.000427	0.000877	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—thyroid cancer	0.000427	0.000876	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000412	0.000845	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000409	0.000839	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—thyroid cancer	0.000398	0.000817	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—thyroid cancer	0.000397	0.000815	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—thyroid cancer	0.000395	0.000811	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—thyroid cancer	0.000387	0.000795	CcSEcCtD
Sitagliptin—Diarrhoea—Epirubicin—thyroid cancer	0.00037	0.000758	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000368	0.000756	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—thyroid cancer	0.000359	0.000736	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—thyroid cancer	0.000357	0.000733	CcSEcCtD
Sitagliptin—Vomiting—Epirubicin—thyroid cancer	0.000343	0.000705	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—thyroid cancer	0.000342	0.000702	CcSEcCtD
Sitagliptin—Rash—Epirubicin—thyroid cancer	0.000341	0.000699	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—thyroid cancer	0.00034	0.000698	CcSEcCtD
Sitagliptin—Headache—Epirubicin—thyroid cancer	0.000338	0.000694	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—thyroid cancer	0.00033	0.000678	CcSEcCtD
Sitagliptin—Nausea—Epirubicin—thyroid cancer	0.000321	0.000658	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—thyroid cancer	0.000318	0.000652	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—thyroid cancer	0.000315	0.000647	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—thyroid cancer	0.000315	0.000646	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—thyroid cancer	0.000313	0.000642	CcSEcCtD
Sitagliptin—Nausea—Doxorubicin—thyroid cancer	0.000297	0.000609	CcSEcCtD
